Carnation Vericap Verruca Treatment 10% w/w medicated plaster

Country: Իռլանդիա

language: անգլերեն

source: HPRA (Health Products Regulatory Authority)

active_ingredient:

Salicylic acid

MAH:

Cuxson Gerrard & Company Ltd

ATC_code:

D02AF

INN:

Salicylic acid

dosage:

10 percent weight/weight

pharmaceutical_form:

Medicated plaster

prescription_type:

Product not subject to medical prescription

therapeutic_area:

Salicylic acid preparations

authorization_status:

Marketed

authorization_date:

1990-01-08

PIL

R20237
Complete and
simple to use
treatment
Salicylic Acid 10% w/w
Contains 4 Medicated Plasters
& Protective Plaster
Vericap
Storage and ingredients
Each medicated verruca plaster contains 6.5mg of Salicylic Acid.
Also contains Microcrystalline Wax and Hydrogenated Vegetable Oil.
Store in the original packaging at less than 25°C, away from direct
sources of heat and humidity.
KEEP OUT OF THE REACH AND SIGHT OF CHILDREN.
Manufactured from
sustainable forests
Manufacturer and Product Authorisation holder
Cuxson Gerrard & Co. Ltd.,
Broadwell Road, Oldbury, West Midlands
B69 4BF, England.
Carnation is a registered trade mark.
Carnation Vericap
Verruca Treatment
Salicylic Acid 10% w/w
Vericap medicated plasters contain
a Salicylic Acid paste that helps to
remove verrucas while a felt ring
relieves pressure.
Recommended for
the removal of verrucas.
Caution
FOR EXTERNAL USE ON THE FEET ONLY.
DO NOT USE:-
-
IF YOU ARE DIABETIC
-
if you have a circulatory disorder
-
if skin close to the verruca is inflamed
or broken
-
if you are using any other medicated
product to treat your verruca
-
to treat more than 3 verrucas at a time
-
for any other purpose than the
removal of verrucas
-
on moles, birthmarks, hairy or genital
warts, the face or anogenital skin
-
if you are allergic to Salicylic Acid,
NSAIDs (asprin), adhesive plasters or
any of the ingredients
-
on children under 6 or adults over 50
-
if you have gangrene
-
after the expiry date shown on this
carton and inner sachets
-
if you are pregnant or breast feeding
Date of Information October 2018
PA 229/3/3
Directions for Use
1. For better adhesion clean and dry the
feet.
2. Take a medicated plaster from its sachet
and remove the backing paper.
3. Firmly apply the medicated plaster,
ensuring that the paste is over the
verruca.
4. Change the medicated plaster every two
days, cleaning the surrounding area and
gently removing any dead skin. Repeat
this treatment until all 4 medicated
plasters have been used over an 8 day
period.
5. When the 4th medicated plaster has
been r

SPC

Health Products Regulatory Authority
15 November 2018
CRN008K10
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Carnation Vericap Verruca Treatment 10% w/w medicated plaster
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each medicated plaster contains 6.5mg of salicylic acid.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Medicated Plaster
Carnation Vericap Verruca Treatment consists of a set of 4 sealed foil
sachets each
containing a medicated plaster and one sealed foil sachet containing a
non-medicated protective plaster.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
A keratolytic for treatment of verrucas.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Carnation Vericap Verruca Treatment plasters are applied topically to
the infected
site.
_RECOMMENDED DOSAGE SCHEDULES:_
_ADULTS_
A medicated dressing is applied to the verruca with the paste well
over the verruca.
Retain in place for 2 days and remove. Any loose skin is gently
scraped away, the
area cleaned and thoroughly dried and a fresh medicated dressing
applied. Repeat
this procedure over an eight day period. Apply protective plaster
dressing to area to
prevent infection and allow healing. If verruca is still present after
four weeks, repeat
treatment. Treatment is suitable for children over 6 years and adults.
Always consult the doctor before using this treatment in adults over
50 years.
_CHILDREN_
Always consult the doctor before using this treatment in children
under 6 years.
Health Products Regulatory Authority
15 November 2018
CRN008K10
Page 2 of 5
4.3 CONTRAINDICATIONS
Not to be used by diabetics. People with severe circulation problems
should seek
medical advice before use.
Do not use if skin close to the verruca is inflamed or broken.
Do not use if hypersensitive/allergic to salicylic acid, any of the
components of the
preparation or other NSAIDs due to the risk of cross reactivity.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Dressing should be removed if excess discomfort is experienced, or if
t